Topography of cortical thinning in the Lewy body diseases

Bakkour, 2009, The cortical signature of prodromal AD: regional thinning predicts mild AD dementia, Neurology, 72, 1048, 10.1212/01.wnl.0000340981.97664.2f Bakkour, 2013, The effects of aging and Alzheimer’s disease on cerebral cortical anatomy: specificity and differential relationships with cognition, Neuroimage, 76, 332, 10.1016/j.neuroimage.2013.02.059 Beekly, 2007, The national Alzheimer's coordinating center (NACC) database: the uniform data set, Alzheimer Dis Assoc Disord, 21, 249, 10.1097/WAD.0b013e318142774e Beyer, 2007, Gray matter atrophy in parkinson disease with dementia and dementia with Lewy bodies, Neurology, 69, 747, 10.1212/01.wnl.0000269666.62598.1c Bickart, 2014, Atrophy in distinct corticolimbic networks in frontotemporal dementia relates to social impairments measured using the social impairment rating scale, J Neurol Neurosurg Psychiatry, 85, 438, 10.1136/jnnp-2012-304656 Borroni, 2015, Structural and functional imaging study in dementia with Lewy bodies and Parkinson's disease dementia, Parkinsonism Relat Disord, 21, 1049, 10.1016/j.parkreldis.2015.06.013 Burton, 2004, Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls, Brain, 127, 791, 10.1093/brain/awh088 Calo, 2016, Synaptic failure and alpha-synuclein, Mov Disord, 31, 169, 10.1002/mds.26479 Colom-Cadena, 2017, Synaptic phosphorylated alpha-synuclein in dementia with Lewy bodies, Brain, 140, 3204, 10.1093/brain/awx275 Compta, 2012, Grey matter volume correlates of cerebrospinal markers of Alzheimer-pathology in Parkinson's disease and related dementia, Parkinsonism Relat Disord, 18, 941, 10.1016/j.parkreldis.2012.04.028 de la Monte, 1989, Neuropathological distinction between Parkinson's dementia and Parkinson's plus Alzheimer's disease, Ann Neurol, 26, 309, 10.1002/ana.410260302 Desikan, 2006, An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest, Neuroimage, 31, 968, 10.1016/j.neuroimage.2006.01.021 Dickerson, 2009, The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals, Cereb Cortex, 19, 497, 10.1093/cercor/bhn113 Dickerson, 2011, Alzheimer-signature MRI biomarker predicts AD dementia in cognitively normal adults, Neurology, 76, 1395, 10.1212/WNL.0b013e3182166e96 Duchaine, 2015, A revised neural framework for face processing, Annu Rev Vis Sci, 1, 393, 10.1146/annurev-vision-082114-035518 Elder, 2017, The influence of hippocampal atrophy on the cognitive phenotype of dementia with Lewy bodies, Int J Geriatr Psychiatry, 32, 1182, 10.1002/gps.4719 Emre, 2007, Clinical diagnostic criteria for dementia associated with Parkinson's disease, Mov Disord, 22, 1689, 10.1002/mds.21507 Ferman, 2004, DLB fluctuations: specific features that reliably differentiate DLB from AD and normal aging, Neurology, 62, 181, 10.1212/WNL.62.2.181 Fischl, 2000, Measuring the thickness of the human cerebral cortex from magnetic resonance images, Proc Natl Acad Sci U S A, 97, 11050, 10.1073/pnas.200033797 Fischl, 1999, Cortical surface-based analysis. II: inflation, flattening, and a surface-based coordinate system, Neuroimage, 9, 195, 10.1006/nimg.1998.0396 Gomperts, 2014, Imaging the role of amyloid in PD dementia and dementia with Lewy bodies, Curr Neurol Neurosci Rep, 14, 472, 10.1007/s11910-014-0472-6 Gomperts, 2016, Tau positron emission tomographic imaging in the Lewy body diseases, JAMA Neurol, 73, 1334, 10.1001/jamaneurol.2016.3338 Gomperts, 2013, Amyloid is linked to cognitive decline in patients with Parkinson disease without dementia, Neurology, 80, 85, 10.1212/WNL.0b013e31827b1a07 Greve, 2016, Different partial volume correction methods lead to different conclusions: an (18)F-FDG-PET study of aging, Neuroimage, 132, 334, 10.1016/j.neuroimage.2016.02.042 Halliday, 2014, The neurobiological basis of cognitive impairment in Parkinson's disease, Mov Disord, 29, 634, 10.1002/mds.25857 Hansen, 2017, In vivo cortical tau in Parkinson's disease using 18F-AV-1451 positron emission tomography, Mov Disord, 32, 922, 10.1002/mds.26961 Harding, 2001, Cortical Lewy body pathology in the diagnosis of dementia, Acta Neuropathol, 102, 355, 10.1007/s004010100390 Harper, 2017, Patterns of atrophy in pathologically confirmed dementias: a voxelwise analysis, J Neurol Neurosurg Psychiatry, 88, 908, 10.1136/jnnp-2016-314978 Huang, 2013, Can we clinically diagnose dementia with Lewy bodies yet?, Transl Neurodegener, 2, 4, 10.1186/2047-9158-2-4 Hughes, 1993, A clinicopathologic study of 100 cases of Parkinson's disease, Arch Neurol, 50, 140, 10.1001/archneur.1993.00540020018011 Hyman, 2012, National institute on aging-alzheimer's association guidelines for the neuropathologic assessment of Alzheimer's disease, Alzheimers Dement, 8, 1, 10.1016/j.jalz.2011.10.007 Kang, 2019, Effects of Lewy body disease and Alzheimer disease on brain atrophy and cognitive dysfunction, Neurology, 92, e2015, 10.1212/WNL.0000000000007373 Kuperberg, 2003, Regionally localized thinning of the cerebral cortex in schizophrenia, Arch Gen Psychiatry, 60, 878, 10.1001/archpsyc.60.9.878 Lee, 2010, A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry, Mov Disord, 25, 28, 10.1002/mds.22858 Lee, 2018, Amyloid-beta-related and unrelated cortical thinning in dementia with Lewy bodies, Neurobiol Aging, 72, 32, 10.1016/j.neurobiolaging.2018.08.007 Litvan, 2012, Diagnostic criteria for mild cognitive impairment in Parkinson’s disease: movement disorder society task force guidelines, Mov Disord, 27, 349, 10.1002/mds.24893 Mak, 2019, Beta amyloid deposition maps onto hippocampal and subiculum atrophy in dementia with Lewy bodies, Neurobiol Aging, 73, 74, 10.1016/j.neurobiolaging.2018.09.004 Mak, 2017, Longitudinal whole-brain atrophy and ventricular enlargement in nondemented Parkinson's disease, Neurobiol Aging, 55, 78, 10.1016/j.neurobiolaging.2017.03.012 McKeith, 2017, Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB consortium, Neurology, 89, 88, 10.1212/WNL.0000000000004058 Moriguchi, 2011, Differential hemodynamic response in affective circuitry with aging: an FMRI study of novelty, valence, and arousal, J Cogn Neurosci, 23, 1027, 10.1162/jocn.2010.21527 Mormino, 2014, Amyloid and APOE epsilon4 interact to influence short-term decline in preclinical Alzheimer disease, . Neurology, 82, 1760, 10.1212/WNL.0000000000000431 Morris, 2006, The uniform data set (UDS): clinical and cognitive variables and descriptive data from alzheimer disease centers, Alzheimer Dis Assoc Disord, 20, 210, 10.1097/01.wad.0000213865.09806.92 Nelson, 2010, Low sensitivity in clinical diagnoses of dementia with Lewy bodies, J Neurol, 257, 359, 10.1007/s00415-009-5324-y Racine, 2018, The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment, Alzheimers Dement (Amst), 10, 301, 10.1016/j.dadm.2018.02.007 Rosas, 2002, Regional and progressive thinning of the cortical ribbon in Huntington’s disease, Neurology, 58, 695, 10.1212/WNL.58.5.695 Salat, 2004, Thinning of the cerebral cortex in aging, Cereb Cortex, 14, 721, 10.1093/cercor/bhh032 Sanchez-Castaneda, 2009, Correlations between gray matter reductions and cognitive deficits in dementia with Lewy bodies and Parkinson's disease with dementia, Mov Disord, 24, 1740, 10.1002/mds.22488 Sarro, 2016, Amyloid-beta deposition and regional grey matter atrophy rates in dementia with Lewy bodies, Brain, 139, 2740, 10.1093/brain/aww193 Schulz-Schaeffer, 2010, The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia. Acta Neuropathol, 120, 131 Shimada, 2013, beta-Amyloid in Lewy body disease is related to Alzheimer's disease-like atrophy, Mov Disord, 28, 169, 10.1002/mds.25286 Siderowf, 2010, CSF amyloid {beta} 1-42 predicts cognitive decline in parkinson disease, Neurology, 75, 1055, 10.1212/WNL.0b013e3181f39a78 Smith, 2018, (18)F-AV-1451 in Parkinson's disease with and without dementia and in dementia with Lewy bodies, Sci Rep, 8, 4717, 10.1038/s41598-018-23041-x Song, 2011, The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status, Mov Disord, 26, 289, 10.1002/mds.23477 Summerfield, 2005, Structural brain changes in parkinson disease with dementia: a voxel-based morphometry study, Arch Neurol, 62, 281, 10.1001/archneur.62.2.281 van der Zande, 2018, Gray matter atrophy in dementia with Lewy bodies with and without concomitant Alzheimer's disease pathology, Neurobiol Aging, 71, 171, 10.1016/j.neurobiolaging.2018.07.005 Watson, 2015, Assessment of regional gray matter loss in dementia with Lewy bodies: a surface-based MRI analysis, Am J Geriatr Psychiatry, 23, 38, 10.1016/j.jagp.2014.07.005 Weintraub, 2011, Neurodegeneration across stages of cognitive decline in parkinson disease, Arch Neurol, 68, 1562, 10.1001/archneurol.2011.725